[1]Khashab M A, Vela M F, Thosani N, et al. ASGE guideline on the management of achalasia[J]. Gastrointest Endosc, 2020, 91(2): 213-227.e6.
[2]Akintoye E, Kumar N, Obaitan I, et al. Peroral endoscopic myotomy: a meta-analysis[J]. Endoscopy, 2016, 48(12): 1059-1068.
[3]Zhang H, Zeng X Y, Huang S, et al. Mid-term and long-term outcomes of peroral endoscopic myotomy for the treatment of achalasia: a systematic review and meta-analysis[J]. Dig Dis Sci, 2023, 68(4): 1386-1396.
[4]Andolfi C, Fisichella P M. Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes[J]. Br J Surg, 2019, 106(4): 332-341.
[5]Urakami S, Abe H, Tanaka S, et al. Development of a preoperative risk-scoring system for predicting poor responders to peroral endoscopic myotomy[J]. Gastrointest Endosc, 2021, 93(2): 398-405.
[6]He Q L, Chen X B, Lu D H, et al. The relationship between cardiac muscularis propria and clinical outcomes of peroral endoscopic myotomy in achalasia[J]. Clin Res Hepatol Gastroenterol, 2021, 45(4): 101529.
[7]Coleman H G, Gray R T, Lau K W, et al. Socio-economic status and lifestyle factors are associated with achalasia risk: a population-based case-control study[J]. World J Gastroenterol, 2016, 22(15): 4002-4008.
[8]Kahrilas P J, Bredenoord A J, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0[J]. Neurogastroenterol Motil, 2015, 27(2): 160-174.
[9]Vaezi M F, Pandolfino J E, Yadlapati R H, et al. ACG clinical guidelines: diagnosis and management of achalasia[J]. Am J Gastroenterol, 2020, 115(9): 1393-1411.
[10]Teitelbaum E N, Dunst C M, Reavis K M, et al. Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders[J]. Surg Endosc, 2018, 32(1): 421-427.
[11]陈志坚, 施慧, 蒋康, 等. 经口内镜下肌切开术治疗贲门失弛缓症术后复发的危险因素[J]. 临床与病理杂志, 2020, 40(1): 102-106.
[12]Pandolfino J E, Kahrilas P J. Smoking and gastro-oesophageal reflux disease[J]. Eur J Gastroenterol Hepatol, 2000, 12(8): 837-842.
[13]Wu X Y, Liu Z Q, Wang Y, et al. The etiology of achalasia: An immune-dominant disease[J]. J Dig Dis, 2021, 22(3): 126-135.
[14]Qiu F F, Liang C L, Liu H Z, et al. Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?[J]. Oncotarget, 2017, 8(1): 268-284.
[15]Li Q L, Wu Q N, Zhang X C, et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months[J]. Gastrointest Endosc, 2018, 87(6): 1405-1412.e3.
|